Moolec Science (MLEC) Research & Development (2022 - 2024)
Moolec Science's (MLEC) quarterly Research & Development came in at -$298003.0 in Q4 2024, up 42.25% year-on-year from -$209492.5 in Q1 2024, and up 29.97% quarter-over-quarter from -$425542.0 in Q3 2024.
Moolec Science (MLEC) Research & Development (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Research & Development across 3 years of filings, most recently posting -$298003.0 for Q4 2024.
- Research & Development for Q4 2024 came in at -$298003.0, up 42.25% year-over-year; the trailing twelve-month figure through Dec 2024 was -$18.6 million (down 6.71% YoY), and the FY2024 annual result was -$17.4 million, down 9.27% from the prior year.
- Research & Development came in at -$298003.0 for Q4 2024 at Moolec Science, up from -$425542.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $176161.0 in Q1 2022 to a low of -$17.4 million in Q2 2024.
- The 3-year median for Research & Development is -$436581.5 (2024), against an average of -$3.6 million.
- Across the five-year window, Research & Development sank 1535.21% in 2023 and surged 42.25% in 2024, its largest moves.
- Moolec Science's Research & Development stood at -$31557.0 in 2022, then tumbled by 1535.21% to -$516022.0 in 2023, then surged by 42.25% to -$298003.0 in 2024.
- The last three Research & Development figures came in at -$298003.0 (Q4 2024), -$425542.0 (Q3 2024), and -$17.4 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -58.00 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -298,003.00 |
| Sep 30, 2024 | -425,542.00 |
| Jun 30, 2024 | -17.42 Mn |
| Mar 31, 2024 | -447,621.00 |
| Dec 31, 2023 | -516,022.00 |
| Sep 30, 2023 | -387,736.00 |
| Jun 30, 2023 | -15.94 Mn |
| Mar 31, 2023 | -576,096.00 |
| Dec 31, 2022 | -31,557.00 |
| Sep 30, 2022 | -372,932.00 |
| Jun 30, 2022 | -7.38 Mn |
| Mar 31, 2022 | 176,161.00 |